Nijmegen, the Netherlands MGI Tech Co., Ltd. (MGI), a company dedicated to developing tools and technologies that drive innovation in life sciences, today announced a major milestone in its collaboration with Predica Diagnostics. Predica’s HPV Profiler and CervicaDx assays, based on its proprietary Cirnaseq technology, have been successfully validated and deployed on MGI’s DNBSEQ sequencing […]

Männedorf, Switzerland — The Tecan Group (SIX Swiss Exchange: TECN) today announced a strategic collaboration with NVIDIA focused on providing the AI-enabled platforms that Data-Driven Laboratories need to achieve faster discoveries and higher lab productivity. Tecan pioneered the transition from manual pipetting to precise, robust, scalable automated pipetting in thousands of labs worldwide. Having led […]

Europa Biosite has announced a new strategic distribution partnership with Quantoom Biosciences, a leading manufacturer of innovative mRNA technologies for global healthcare advancement supporting next generation vaccines and therapeutics. The agreement provides access to Quantoom’s pioneering research RNA production solutions for scientists across Europe. Under the partnership, Europa Biosite will distribute Quantoom’s Ntensify® mano and […]

• Enables researchers worldwide to access high-quality ssDNA oligonucleotides within hours • Establishes direct distribution networks across Latin America, Japan and South Korea Paris, France, 17 March 2026: DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science […]

Collaboration delivers an automated, high-plex molecular testing workflow on Hamilton liquid handling workstations Bonaduz, Switzerland / Stockholm, Sweden – Hamilton and Aplex Bio today announced a co-marketing agreement to jointly promote an automated liquid handling solution for Aplex Bio’s Hyperplex PCR™ (hpPCR™) Assay Kits on Hamilton robotic platforms. The collaboration enables highly automated detection and […]

Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, and A.D.A.M. Innovations (Japanese corporate name Genesis Healthcare Co.), one of Japan’s leading genetic testing companies, today announce an international collaboration to develop and deploy advanced genomic sequencing and medicine applications based on comprehensive, nanopore sequencing in Japan. In […]

The designation builds on the unit’s role as the first G4X Early Access Program site and supports broader global adoption of G4X. San Diego, CA and Boston, MA — Singular Genomics today announced that the Spatial Technologies Unit (STU) at Beth Israel Deaconess Medical Center (BIDMC), a Dana-Farber/Harvard Cancer Center (DF/HCC) Core Facility, has been designated a G4X™ Center of Excellence. The STU […]

Laboratories running wastewater surveillance, bloodstream pathogen detection, or urine-based STI screening no longer need to choose between sample volume and automation. SwiftXtractor™ SL processes up to 40 mL in a single run, replacing manual concentration steps that cost time, introduce variability, and limit throughput. Compact, portable, and ready for your bench.   Hallbergmoos, Germany — […]

Foundational synthesis technology enables scalable modified 100-400nt RNA constructs, speeding design cycles and improving genome-editing precision BOULDER, CO – Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology, giving researchers scalable access to high purity 100-400nt RNA constructs for next-generation therapeutics. The agreement brings to market an approach developed […]

Genomenon’s Curation and Global Distribution of Variant Data Reduces Barriers to Genetic Diagnosis ANN ARBOR, Mich. – Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease. Through this collaboration, Genomenon produced literature-derived real-world evidence by applying fit-for-purpose AI and expert review to curate and classify variants in […]